1-4 of 4
Brandon Carter-Cooper
Close
Sort by
Journal Articles

Long-Acting E. coli -Derived Asparaginase Potentiates the Anti-Leukemic Effect of BCL2 Inhibition, but Not MCL1 Inhibition, in Preclinical Models of Acute Myeloid Leukemia

Dominique Bollino, Andrea Casildo, Xinrong Ma, Kayla M Tighe, Brandon Carter-Cooper, Ashkan Emadi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5739.
https://doi.org/10.1182/blood-2023-178850
Published: 2023
Journal Articles

Presence of Isocitrate Dehydrogenase (IDH) Mutations May Predict Clinical Response to Hypomethylating Agents in Patients with Acute Myeloid Leukemia (AML)

Elizabeth A. Griffiths, MD, Brandon Carter-Cooper, BS, Seda Tolu, BS, Laurie A Ford, BS, CCRC, Rena G. Lapidus, PhD, Meir Wetzler, MD, Eunice S. Wang, MD, Arash Etemadi, MD PhD, Ashkan Emadi, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 3724.
https://doi.org/10.1182/blood.V124.21.3724.3724
Published: 2014
Journal Articles

Synergistic Antileukemic Effect Of Sequential Administration Of Dichloroacetate (DCA) Combined With Arsenic Trioxide (ATO) In Primary Blasts From Patients With Acute Myeloid Leukemia (AML) and FLT3-ITD AML Cell Lines

Ashkan Emadi, M.D., Ph.D., Brandon Carter-Cooper, BS, Mariola Sadowska, PhD, Omasiri Wonodi, BS, Rena G. Lapidus, PhD, Mark Levis, MD, PhD, Edward A. Sausville, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3955.
https://doi.org/10.1182/blood.V122.21.3955.3955
Published: 2013
Journal Articles

Dimeric Naphthoquinones: Novel Anti-Leukemic Agents Modulating Cellular Redox Status

Ashkan Emadi, M.D., Ph.D., Mariola Sadowska, PhD, Brandon Carter-Cooper, BS, Omasiri Wonodi, BS, Nidal Muvarak, BS, Feyruz Rassool, PhD, Anil Jaiswal, PhD, Maria R. Baer, MD, Rena G. Lapidus, PhD, Edward A. Sausville, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1290.
https://doi.org/10.1182/blood.V122.21.1290.1290
Published: 2013